33 /100
MEDIUM RISK
Score updated May 30, 2026

EDIT — Editas Medicine, Inc. Dilution Risk Tracker

Track EDIT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EDIT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
12%
📉 Score Deterioration 25%
• Score increased 13 points recently (worsening)
🔔 Track EDIT — Get forecast alerts →

💹 Market Data

Market Cap$530.98M
Shares Outstanding153.46M
Float97.73M
Cash$123.65M
Debt$17.30M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 13.4% shares (2025Q4 vs prior)
199 institutional holders · 52.30M shares
#1 BlackRock, Inc. 9.35M shares
#2 VANGUARD GROUP INC 8.21M shares
#3 RENAISSANCE TECHNOLOGIES LLC 3.04M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.56M
Days to Cover8.6
% of Float9.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2016
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Mar 04, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track EDIT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EDIT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for EDIT
📊 EDIT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EDIT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.